Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sang Hee Cho

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Cancer Research and Treatment|January 24, 2014
Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapyDae-Eun Kim, Uh-Jin Kim, Won-Young Choi, et al.
BMC Cancer|March 19, 2013
Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neckWoo Kyun Bae, Jun Eul Hwang, Hyun Jeong Shim, et al.
Cancer Science|June 14, 2020
Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancerChang-Soo Hong, Eun-Gene Sun, Ji-Na Choi, et al.
Oncotarget|October 15, 2017
The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysisJun Eul Hwang, Myung Seo Ki, Karham Kim, et al.
Chonnam Medical Journal|February 2, 2024
Comparative Study on the Immunogenicity of COVID-19 mRNA Vaccines in Patients Receiving Adjuvant and Palliative ChemotherapyHyun-Woo Choi, Younggon Jung, Uh Jin Kim, et al.
BMC Cancer|September 24, 2013
Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancerJun-Eul Hwang, Ji-Yun Hong, Karham Kim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2025
The association between genetically predicted C-reactive protein levels and risk of colorectal cancer in an East Asian population: two-sample Mendelian randomizationChang Kyun Choi, Jung-Ho Yang, Min-Ho Shin, et al.
Cancer Research and Treatment|February 4, 2025
Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH TrialKyoo Hyun Kim, Shinwon Hwang, Min Kyoung Kim, et al.
Medicine|May 26, 2018
Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer: A multicenter retrospective analysisSo Yeon Lee, Yoon Seok Choi, Ik-Chan Song, et al.
Clinical & Experimental Metastasis|August 27, 2013
Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancerJun-Eul Hwang, Seung-Hun Kim, Joon Jin, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Cancer Research and Treatment|January 24, 2014
Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapyDae-Eun Kim, Uh-Jin Kim, Won-Young Choi, et al.
BMC Cancer|March 19, 2013
Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neckWoo Kyun Bae, Jun Eul Hwang, Hyun Jeong Shim, et al.
Cancer Science|June 14, 2020
Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancerChang-Soo Hong, Eun-Gene Sun, Ji-Na Choi, et al.
Oncotarget|October 15, 2017
The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysisJun Eul Hwang, Myung Seo Ki, Karham Kim, et al.
Chonnam Medical Journal|February 2, 2024
Comparative Study on the Immunogenicity of COVID-19 mRNA Vaccines in Patients Receiving Adjuvant and Palliative ChemotherapyHyun-Woo Choi, Younggon Jung, Uh Jin Kim, et al.
BMC Cancer|September 24, 2013
Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancerJun-Eul Hwang, Ji-Yun Hong, Karham Kim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2025
The association between genetically predicted C-reactive protein levels and risk of colorectal cancer in an East Asian population: two-sample Mendelian randomizationChang Kyun Choi, Jung-Ho Yang, Min-Ho Shin, et al.
Cancer Research and Treatment|February 4, 2025
Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH TrialKyoo Hyun Kim, Shinwon Hwang, Min Kyoung Kim, et al.
Medicine|May 26, 2018
Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer: A multicenter retrospective analysisSo Yeon Lee, Yoon Seok Choi, Ik-Chan Song, et al.
Clinical & Experimental Metastasis|August 27, 2013
Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancerJun-Eul Hwang, Seung-Hun Kim, Joon Jin, et al.
Pageof 15